As oncology treatment enters the era of targeted therapy, precision medicines for renal cell carcinoma (RCC) continue to emerge, offering patients longer survival and improved quality of life. Saibeixin® Pazopanib Tablets, a domestically developed first generic of pazopanib manufactured by Qilu Pharmaceutical, have become an important treatment option for advanced RCC. With proven efficacy,...